Study of risks in superficial radiotherapy with SENSUS SRT-100TM using FMEA and code SECURE MR-FMEA

• Main Authors: Julio Nazco Torres, Antonio Torres Valle, Juan Francisco Labrador Díaz, Ulises Jiménez Ortega, Diosdado Castro Crespo
• Format: Article
• Language: Spanish
• Published: ECIMED 2018-10-01
• Series: Revista de Ciencias Médicas de Pinar del Río
• Subjects: DISEÑO DE PROGRAMAS INFORMÁTICOS; CALIDAD DE VIDA; RIESGO; RADIOTERAPIA.
• Online Access: http://www.revcmpinar.sld.cu/index.php/publicaciones/article/view/3762

Introduction: in view of the high incidence of skin cancer, where treatments with ionizing radiation are used, particularly with SENSUS SRT-100TM equipment at Oncology Patient Care Center of Pinar del Río, and the known need to improve the prevention of incidents and accidents related to this practice, an advanced risk-analysis approach, similar to that proposed by the American Association of Physicists in Medicine, was applied using the SECURE MR-FMEA code. Objective: to develop a risk study for superficial radiotherapy with SENSUS SRT 100TM that identifies the modes and causes of failures associated with the treatment, which allow the use of applications that optimize the safety and quality of the practice. Methods: the prospective method of failure modes and effect analysis, regarding superficial treatments with SENSUS SRT-100TM through the applications developed by means of the SECURE MR-FMEA code. Results: the process map was designed with its sub-processes and respective stages by a multidisciplinary team created at Oncology Patient Care Center in Pinar del Río, assisting the global comprehension of the activity and determining the risk profile and specific failure trees (supported by the benefits of the SECURE MR-FMEA program), to create defense measures and developing activities that decreased the risk after the application of the reassessment. Conclusions: the risk study carried out in superficial radiotherapy made possible to strengthen the safety and quality of the treatments delivered at the Oncology Patient Care Center of Pinar del Río, allowing the future assessments